| Net Cash Provided by (Used in) Operating Activities |
$-11,452,000 |
USD |
75% |
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$62,010,000 |
USD |
11% |
Q3 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$52,509,000 |
USD |
|
Q3 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
750,000,000 |
shares |
0% |
Q2 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
454,015,855 |
shares |
10.6% |
Q2 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$158,137,000 |
USD |
66.8% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$96,976,000 |
USD |
23.2% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$101,395,000 |
USD |
25.5% |
Q2 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$1,219,000 |
USD |
100% |
Q3 2024 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$-88,244,000 |
USD |
-124% |
Q2 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$78,229,000 |
USD |
175% |
Q2 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$-2,779,000 |
USD |
44.8% |
Q2 2025 |
FY 2025 |
| Additional Paid in Capital |
$1,404,420,000 |
USD |
26.5% |
Q2 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$598,000 |
USD |
15.7% |
Q3 2024 |
Q1 2025 |
| Interest Expense |
$1,446,000 |
USD |
74.8% |
Q2 2025 |
FY 2025 |